THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL (CAST)

被引：151

作者：

RUSKIN, JN

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1989年 / 321卷 / 06期

关键词：

D O I：

10.1056/NEJM198908103210608

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：386 / 388

页数：3

共 9 条

[1]

[Anonymous], 1989, NEW ENGL J MED, V321, P406

[2]

[Anonymous], 1988, AM J CARDIOL, V61, P501

[3] EVALUATION OF ANTIARRHYTHMIC DRUGS ON DEFIBRILLATION ENERGY-REQUIREMENTS IN DOGS - SODIUM-CHANNEL BLOCK AND ACTION-POTENTIAL PROLONGATION [J].

ECHT, DS ;

BLACK, JN ;

BARBEY, JT ;

COXE, DR ;

CATO, E .

CIRCULATION, 1989, 79 (05) :1106-1117

[4]

HERRE JM, 1988, CIRCULATION S2, V78, P61

[5] CLINICAL CHARACTERISTICS OF PATIENTS WITH VENTRICULAR-FIBRILLATION DURING ANTIARRHYTHMIC DRUG-THERAPY [J].

MINARDO, JD ;

HEGER, JJ ;

MILES, WM ;

ZIPES, DP ;

PRYSTOWSKY, EN .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (05) :257-262

[6] CLASSIFICATION BY TYPE OF VENTRICULAR ARRHYTHMIA PREDICTS FREQUENCY OF ADVERSE CARDIAC EVENTS FROM FLECAINIDE [J].

MORGANROTH, J ;

ANDERSON, JL ;

GENTZKOW, GD .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (03) :607-615

[7]

PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801

[8] DRUG CONVERSION OF NON-SUSTAINED VENTRICULAR-TACHYCARDIA TO SUSTAINED VENTRICULAR-TACHYCARDIA DURING SERIAL ELECTROPHYSIOLOGIC STUDIES - IDENTIFICATION OF DRUGS THAT EXACERBATE TACHYCARDIA AND POTENTIAL MECHANISMS [J].

RINKENBERGER, RL ;

PRYSTOWSKY, EN ;

JACKMAN, WM ;

NACCARELLI, GV ;

HEGER, JJ ;

ZIPES, DP .

AMERICAN HEART JOURNAL, 1982, 103 (02) :177-184

[9] MALIGNANT VENTRICULAR TACHYARRHYTHMIAS ASSOCIATED WITH THE USE OF ENCAINIDE [J].

WINKLE, RA ;

MASON, JW ;

GRIFFIN, JC ;

ROSS, D .

AMERICAN HEART JOURNAL, 1981, 102 (05) :857-864

← 1 →